Persistent abnormal liver fibrosis after weaning off parenteral nutrition in pediatric intestinal failure

Hepatology

Volumn 58, Issue 2, 2013, Pages 729-738

  Mutanen, Annika ^a   Lohi, Jouko ^b   Heikkilä, Päivi ^b   Koivusalo, Antti I ^a   Rintala, Risto J ^a   Pakarinen, Mikko P ^a  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHILD; CHILDHOOD DISEASE; CHOLESTASIS; CLINICAL ARTICLE; DISEASE SEVERITY; ECHOGRAPHY; ESOPHAGUS VARICES; FEMALE; GASTROSCOPY; HEPATITIS; HIRSCHSPRUNG DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEOCECAL VALVE; INFANT; INTESTINAL DYSMOTILITY; INTESTINAL FAILURE; INTESTINE ATRESIA; INTESTINE PSEUDOOBSTRUCTION; INTESTINE VOLVULUS; LIVER BIOPSY; LIVER FIBROSIS; LIVER TRANSPLANTATION; MALE; MEDICAL RECORD REVIEW; NECROTIZING ENTEROCOLITIS; ORGAN DONOR; PARENTERAL NUTRITION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; SHORT BOWEL SYNDROME; STEATOSIS;

ADOLESCENT; ADULT; BIOPSY; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT; INTESTINAL DISEASES; LIVER; LIVER CIRRHOSIS; MALE; PARENTERAL NUTRITION; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY; YOUNG ADULT;

EID: 84881029256     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26360     Document Type: Article

References (47)

1. Goulet O, Ruemmele F, Lacaille F, Colomb V. Irreversible intestinal failure. J Pediatr Gastroenterol Nutr 2004;38:250-269.
2. Carter BA, Karpen SJ. Intestinal failure-associated liver disease: management and treatment strategies past, present, and future. Semin Liver Dis 2007;27:251-258.
3. Kelly DA. Intestinal failure-associated liver disease: what do we know today? Gastroenterology 2006;130(2 Suppl 1):S70-S77.
4. D'Antiga L, Goulet O. Intestinal failure in children: the European view. J Pediatr Gastroenterol Nutr 2013;56:118-126.
5. Pironi L, Goulet O, Buchman A, Messing B, Gabe S, Candusso M, et al. Outcome on home parenteral nutrition for benign intestinal failure: a review of the literature and benchmarking with the European prospective survey of ESPEN. Clin Nutr 2012;31:831-845.
6. Beath SV, Davies P, Papadopoulou A, Khan AR, Buick RG, Corkery JJ, et al. Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors. J Pediatr Surg 1996;31:604-606.
7. Clayton PT, Whitfield P, Iyer K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition 1998;14:158-164.
8. Spencer AU, Neaga A, West B, Safran J, Brown P, Btaiche I, et al. Pediatric short bowel syndrome: redefining predictors of success. Ann Surg 2005;242:403-409.
9. Kelly DA. Preventing parenteral nutrition liver disease. Early Hum Dev 2010;86:683-687.
10. Kurvinen A, Nissinen MJ, Andersson S, Korhonen P, Ruuska T, Taimisto M, et al. Parenteral plant sterols and intestinal failure-associated liver disease in neonates. J Pediatr Gastroenterol Nutr 2012;54:803-811.
11. Cohen C, Olsen MM. Pediatric total parenteral nutrition. Liver histopathology. Arch Pathol Lab Med 1981;105:152-156.
12. Fitzgibbons SC, Jones BA, Hull MA, Zurakowski D, Duro D, Duggan C, et al. Relationship between biopsy-proven parenteral nutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome. J Pediatr Surg 2010;45:95-99.
13. Peyret B, Collardeau S, Touzet S, Loras-Duclaux I, Yantren H, Michalski MC, et al. Prevalence of liver complications in children receiving long-term parenteral nutrition. Eur J Clin Nutr 2011;65:743-749.
14. Pichler J, Horn V, MacDonald S, Hill S. Sepsis and its etiology among hospitalized children less than 1 year of age with intestinal failure on parenteral nutrition. Transplant Proc 2010;42:24-25.
15. Rodgers BM, Hollenbeck JI, Donnelly WH, Talbert JL. Intrahepatic cholestasis with parenteral alimentation. Am J Surg 1976;131:149-155.
16. Dahms BB, Halpin TC, Jr. Serial liver biopsies in parenteral nutrition-associated cholestasis of early infancy. Gastroenterology 1981;81:136-144.
17. Moss RL, Das JB, Raffensperger JG. Total parenteral nutrition-associated cholestasis: clinical and histopathologic correlation. J Pediatr Surg 1993;28:1270-1274.
18. Hasegawa T, Sasaki T, Kimura T, Nakai H, Sando K, Wasa M, et al. Effects of isolated small bowel transplantation on liver dysfunction caused by intestinal failure and long-term total parenteral nutrition. Pediatr Transplant 2002;6( 3):235-239.
19. Vileisis RA, Sorensen K, Gonzalez-Crussi F, Hunt CE. Liver malignancy after parenteral nutrition. J Pediatr 1982;100:88-90.
20. Yeop I, Taylor CJ, Narula P, Johnson L, Bowen C, Gupte GL. Hepatocellular carcinoma in a child with intestinal failure-associated liver disease. J Pediatr Gastroenterol Nutr 2012;54:695-697.
21. Potter C, Hogan MJ, Henry-Kendjorsky K, Balint J, Barnard JA. Safety of pediatric percutaneous liver biopsy performed by interventional radiologist. J Pediatr Gastroenterol Nutr 2011;53:202-206.
22. Pakarinen MP, Kurvinen A, Koivusalo AI, Iber T, Rintala RJ. Long-term controlled outcomes after autologous intestinal reconstruction surgery in treatment of severe short bowel syndrome. J Pediatr Surg 2013;48:339-344.
23. Pakarinen MP, Kurvinen A, Koivusalo AI, Makisalo H, Jalanko H, Rintala RJ. Surgical treatment and outcomes of severe pediatric intestinal motility disorders requiring parenteral nutrition. J Pediatr Surg 2013;48:333-338.
24. Pakarinen MP, Koivusalo AI, Rintala RJ. Outcomes of intestinal failure-a comparison between children with short bowel syndrome and dysmotile intestine. J Pediatr Surg 2009;44:2139-2144.
25. Lampela H, Kosola S, Koivusalo A, Lauronen J, Jalanko H, Rintala R, Pakarinen M. Endoscopic surveillance and primary prophylaxis sclerotherapy of esophageal varices in biliary atresia. J Pediatr Gastroenterol Nutr 2012;55:574-579.
26. Struijs MC, Diamond IR, de Silva N, Wales PW. Establishing norms for intestinal length in children. J Pediatr Surg 2009;44:933-938.
27. Messing B, Crenn P, Beau P, Boutron-Ruault MC, Rambaud JC, Matuchansky C. Long-term survival and parenteral nutrition dependence in adult patients with the shot bowel syndrome. Gastroenterology 1999;117:1043-1050.
28. Saari A, Sankilampi U, Hannila ML, Kiviniemi V, Kesseli K, Dunkel L. New Finnish growth references for children and adolescents aged 0 to 20 years: length/height-for-age, weight-for-length/height, and body mass index-for-age. Ann Med 2011;43:235-248.
29. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-526.
30. Scheuer PJ, Lefkowitch PJ. Assessment and differential diagnosis of pathological features. In: Scheuer PJ, Lefkowitch PJ, eds. Liver Biopsy Interpretation. Volume 1, 7th ed. Philadelphia, PA: Elsevier Saunders; 2006:35-51.
31. Bedossa P, Poynard T. An algoritm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group. Hepatology 1996;24:289-293.
32. Postuma R, Trevenen CL. Liver disease in infants receiving total parenteral nutrition. Pediatrics 1979;63:110-115.
33. Benjamin DR. Hepatobiliary dysfunction in infants and children associated with long-term total parenteral nutrition. A clinico-pathologic study. Am J Clin Pathol 1981;76:276-283.
34. Quigley EM, Marsh MN, Shaffer JL, Markin RS. Hepatobiliary complications of total parenteral nutrition. Gastroenterology 1993;104:286-301.
35. Zambrano E, El-Hennawy M, Ehrenkranz RA, Zelterman D, Reyes-Múgica M. Total parenteral nutrition induced liver pathology: an autopsy series of 24 newborn cases. Pediatr Dev Pathol 2004;7:425-432.
36. Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease and permanent intestinal failure. Ann intern Med 2000;132:525-532.
37. Gura KM, Lee S, Valim C, Zhou J, Kim S, Modi BP, et al. Safety and efficacy of fish-oil-based fat emulsions in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008;121:e678-e686.
38. Soden JS, Lovell MA, Brown K, Partrick DA, Sokol RJ. Failure of resolution of portal fibrosis during omega-3 fatty acid lipid emulsion therapy in two patients with irreversible intestinal failure. J Pediatr 2010;156:327-331.
39. Deitch EA, Xu D, Qi L, Specian RD, Berg RD. Protein malnutrition alone and in combination with endotoxin impairs systemic and gut-associated immunity. JPEN J Parenter Enteral Nutr 1992;16:25-31.
40. Cesaro C, Tiso A, Del Prete A, Cariello R, Tuccillo C, Cotticelli G, et al. Gut microbiota and probiotics in chronic liver disease. Dig Liver Dis 2011;43:431-438.
41. Dibaise JK, Young RJ, Vanderhoof JA. Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome. Clin Gastroenterol Hepatol 2006;4:11-20.
42. El Kasmi KC, Anderson AL, Devereaux MW, Fillon SA, Harris JK, Lovell MA, et al. Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal failure. Hepatology 2012;55:1518-1528.
43. Urao M, Okuyama H, Drongowski RA, Teitelbaum DH, Coran AG. Intestinal premiability to small- and large-molecular-weight substances in the newborn rabbit. J Pediatr Surg 1997;32:1424-1428.
44. Yang H, Finaly R, Teitelbaum DH. Alteration in epithelial premiability and ion transport in a mouse model of total parenteral nutrition. Crit Care Med 2003;31:1118-1125.
45. Cavicci M, Crenn P, Beau P, Degott C, Boutron MC, Messing B. Severe liver complications associated with long-term parenteral nutrition are dependent on lipid parenteral input. Transplant Proc 1998;30:2547.
46. de Lédinghen V, Le Bail B, Rebouissoux L, Fournier C, Foucher J, Miette V, et al. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr 2007;45:443-450.
47. Mirtallo J, Canada T, Johnson D, Kumpf V, Petersen C, Sacks G, et al. Safe practices for parenteral nutrition, JPEN J Parenter Enteral Nutr 2004;28:S39-S70.